Do glucosamine and chondroitin treat the symptoms of osteoarthritis?

Canadian Family Physician

Volumn 47, Issue FEB., 2001, Pages 275-277

  Edelist, Darren D ^a   Evans, Michael F ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN; CYCLOOXYGENASE 2 INHIBITOR; GLUCOSAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; GENERAL PRACTITIONER; HUMAN; MEDICAL PRACTICE; OSTEOARTHRITIS; QUALITY OF LIFE; REVIEW; SYMPTOM;

CHONDROITIN; CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; GLUCOSAMINE; HUMANS; OSTEOARTHRITIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0035106003     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Felson DT. Osteoarthritis. Rheum Dis Clin North Am 1990;16:499-512.
2. Guccione AA, Felson DT, Anderson JJ, Anthony JM, Zhang Y, Wilson PW. The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health 1994;84:351-8.
3. Kramer JS, Yclin EH, Epstein WV. Social and economic impacts of four musculoskeletal conditions: a study using national community-based data. J Rheumatol 1983;26:901-7.
4. Setnikar I, Cereda R, Pacini MA, Revel L. Antireactive properties of glucosamine sulfate. Arzneimittelforschung 1991;41:157-61.
5. Ronca F, Palmieri L, Panicucci P, Ronca G. Anti-inflammatory activity of chondroitin sulfate. Osteoarth Cartilage 1998;6(Suppl A):14-21.
6. Bassleer CT, Combal JP, Bougaret S, Malaise M. Effects of chondroitin sulfate and interleukin-1 beta on human articular chondrocytes cultivated in clusters. Osteoarth Cartilage 1998;6:196-204.
7. Bassleer CT, Rovati L, Franchimont P. Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro. Osteoarth Cartilage 1998;6:427-34.
8. Reginster JY, Deroisy R, Paul I. Glucosamine sulfate significantly reduces progression of knee osteoarthritis over 3 years. Arthritis Rheum 1999;42(Suppl 9):S400.
9. Verbruggen G, Goemaere S, Veys EM. Chondroitin sulfate: S/DMOAD (structure/disease modifying anti-arthritis drug) in the treatment of finger joint OA. Osteoarth Cartilage 1998;6(Suppl A):37-8.
10. Uebelhart D, Thonar EJ, Delmas PD, Chantraine A, Vignon E. Effects of oral chondroitin on the progression of knee osteoarthritis: a pilot study. Osteoarth Cartilage 1998;6(Suppl A):6-13.
11. Altman R, Brandt KD, Hochberg MC, Moskowitz R. Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Osteoarth Cartilage 1996;4:21743.
12. Chalmers TC, Smith H Jr, Blackburn B, Silverman B, Schroeder B, Reitman D. A method for assessing the quality of a randomized control trial. Control Clin Trials 1981;2:31-49.
13. Rochon PA, Gurwitz JH, Cheung CM, Hayes JA, Chalmers TC. Evaluating the quality of articles published in journal supplements compared with the quality of those published in the parent journal. JAMA 1994;272:108-13.
14. Oxman AD, Cook DJ, Guyatt GH. Dsers' guides to the medical literature. VI: How to use an overview. JAMA 1994;272:1367-72.